Labeler
NorthStar Rx LLC NDC Codes
NorthStar Rx LLC lists 443 finished drug products in the FDA NDC Directory under NDC labeler codes 16714, 72603.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Bumetanide, Tadalafil, Clozapine, Rosuvastatin Calcium, Diclofenac Sodium, Labetalol Hydrochloride, Sildenafil Citrate, Carbamazepine, Fluoxetine, Desvenlafaxine, Midodrine Hydrochloride, Losartan Potassium and Hydrochlorothiazide, Estradiol, Tranexamic Acid, Doxepin
- Active ingredients
- Bumetanide, Tadalafil, Clozapine, Rosuvastatin calcium, Diclofenac sodium, Labetalol hydrochloride, Sildenafil citrate, Carbamazepine, Fluoxetine hydrochloride, Desvenlafaxine succinate, Midodrine hydrochloride, Losartan potassium
- NDC labeler codes
- 16714, 72603
- Strengths (from the 100 most recently listed products)
- Bumetanide .5 mg/1; Bumetanide 1 mg/1; Bumetanide 2 mg/1; Losartan potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1; Colestipol hydrochloride 1 g/1; Tadalafil 2.5 mg/1; Tadalafil 5 mg/1; Tadalafil 10 mg/1; Tadalafil 20 mg/1; Tranexamic acid 650 mg/1; Clozapine 25 mg/1; Clozapine 50 mg/1; Clozapine 100 mg/1; Clozapine 200 mg/1; Doxepin hydrochloride 3 mg/1; Doxepin hydrochloride 6 mg/1; Progesterone 100 mg/1; Progesterone 200 mg/1; Ibuprofen 600 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Tablet, Extended release, Injection, Solution, Tablet, Delayed release, Solution, Injection, Capsule, Delayed release, Powder, For solution, Powder, For suspension, Shampoo, Suspension, Injection, Powder, Lyophilized, For suspension, Kit, Powder, Spray, Metered, Gel, Ointment, Cream, Injection, Powder, For solution
- Routes
- Oral, Topical, Intravenous, Subcutaneous, Perineural, Intramuscular, Vaginal, Nasal, Infiltration
- Drug classes (FDA established)
- Phosphodiesterase 5 Inhibitor, Loop Diuretic, Nonsteroidal Anti-inflammatory Drug, Mood Stabilizer, Atypical Antipsychotic, HMG-CoA Reductase Inhibitor, Estrogen, Anti-epileptic Agent, beta-Adrenergic Blocker, Osmotic Laxative, Serotonin Reuptake Inhibitor, Serotonin and Norepinephrine Reuptake Inhibitor, alpha-Adrenergic Agonist, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Antifibrinolytic Agent, Tricyclic Antidepressant, Progesterone, Proton Pump Inhibitor, Microtubule Inhibitor, Potassium Salt, Chloride Channel Activator, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Amide Local Anesthetic, Lincosamide Antibacterial, Corticosteroid, Thyroid Hormone Synthesis Inhibitor, Central alpha-2 Adrenergic Agonist, Bile Acid Sequestrant, GLP-1 Receptor Agonist, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor, Nucleoside Analog Antiviral, Antimetabolite Immunosuppressant, Leukocyte Growth Factor, Azole Antifungal, Polyene Antifungal, Histamine-1 Receptor Antagonist, Bile Acid, Central Nervous System Stimulant, Aromatase Inhibitor, Opioid Agonist, Androgen, alpha-Adrenergic Blocker, Penicillin-class Antibacterial
- Package NDCs
- 150 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| testosterone | Testosterone 40.5 mg/2.5g | GelTopical | 16714-969 | 16714-0969-02 | — |
| testosterone | Testosterone 20.25 mg/1.25g | GelTopical | 16714-968 | 16714-0968-02 | — |
| Omeprazole | Omeprazole 10 mg/1 | Capsule, Delayed releaseOral | 16714-714 | 16714-0714-01 | — |
| Omeprazole | Omeprazole 40 mg/1 | Capsule, Delayed releaseOral | 16714-123 | 16714-0123-0116714-0123-0216714-0123-03 | — |
| Carbidopa | Carbidopa 25 mg/1 | TabletOral | 16714-067 | 16714-0067-01 | — |
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | 16714-996 | 16714-0996-0116714-0996-02 | — |
| Hydroxychloroquine sulfate | Hydroxychloroquine sulfate 200 mg/1 | Tablet, Film coatedOral | 16714-110 | 16714-0110-0116714-0110-02 | — |
| Rivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | 16714-116 | 16714-0116-02 | — |
| Rivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | 16714-117 | 16714-0117-02 | — |
| Fluoxetine hydrochloride | Fluoxetine hydrochloride 60 mg/1 | Tablet, Film coatedOral, Oral | 16714-114 | 16714-0114-01 | — |
| Fluoxetine | Fluoxetine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 16714-112 | 16714-0112-0116714-0112-02 | — |
| Fluoxetine | Fluoxetine hydrochloride 20 mg/1 | Tablet, Film coatedOral | 16714-113 | 16714-0113-0116714-0113-02 | — |
| Esomeprazole Magnesium | Esomeprazole magnesium 20 mg/1 | Capsule, Delayed releaseOral | 16714-979 | 16714-0979-0116714-0979-02 | — |
| Esomeprazole Magnesium | Esomeprazole magnesium 40 mg/1 | Capsule, Delayed releaseOral | 16714-980 | 16714-0980-0116714-0980-0216714-0980-03 | — |
| Fosaprepitant | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 72603-450 | 72603-0450-01 | — |
| ezetimibe and simvastatin | Ezetimibe 10 mg/1; Simvastatin 40 mg/1 | TabletOral | 16714-780 | 16714-0780-0116714-0780-02 | — |
| ezetimibe and simvastatin | Ezetimibe 10 mg/1; Simvastatin 80 mg/1 | TabletOral | 16714-781 | 16714-0781-0116714-0781-02 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 72603-301 | 72603-0301-01 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 72603-101 | 72603-0101-01 | — |
| Permethrin | Permethrin 50 mg/g | CreamTopical | 16714-897 | 16714-0897-01 | — |
| Aspirin and Dipyridamole | Aspirin 25 mg/1; Dipyridamole 200 mg/1 | Capsule, Extended releaseOral | 16714-964 | 16714-0964-01 | — |
| Atenolol and Chlorthalidone | Atenolol 100 mg/1; Chlorthalidone 25 mg/1 | TabletOral | 16714-937 | 16714-0937-01 | — |
| Atenolol and Chlorthalidone | Atenolol 50 mg/1; Chlorthalidone 25 mg/1 | TabletOral | 16714-936 | 16714-0936-01 | — |
| Tretinoin | Tretinoin .5 mg/g | CreamTopical | 16714-249 | 16714-0249-0116714-0249-02 | — |
| Tretinoin | Tretinoin 1 mg/g | CreamTopical | 16714-250 | 16714-0250-0116714-0250-02 | — |
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | 16714-859 | 16714-0859-01 | — |
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | 16714-857 | 16714-0857-01 | — |
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | 16714-858 | 16714-0858-01 | — |
| Bleomycin | Bleomycin sulfate 15 [USP'U]/1 | Powder, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous | 16714-886 | 16714-0886-01 | — |
| Glipizide | Glipizide 10 mg/1 | Tablet, Extended releaseOral | 16714-896 | 16714-0896-0116714-0896-02 | — |
| Glipizide | Glipizide 2.5 mg/1 | Tablet, Extended releaseOral | 16714-894 | 16714-0894-01 | — |
| Glipizide | Glipizide 5 mg/1 | Tablet, Extended releaseOral | 16714-895 | 16714-0895-0116714-0895-02 | — |
| Bleomycin | Bleomycin sulfate 30 [USP'U]/1 | Powder, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous | 16714-908 | 16714-0908-01 | — |
| Lamotrigine | Lamotrigine 250 mg/1 | Tablet, Extended releaseOral | 16714-893 | 16714-0893-01 | — |
| Gemcitabinegemcitabine hydrochloride | Gemcitabine hydrochloride 200 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 16714-909 | 16714-0909-01 | — |
| Gemcitabinegemcitabine hydrochloride | Gemcitabine hydrochloride 1 g/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 16714-930 | 16714-0930-01 | — |
| Clomipramine Hydrochloride | Clomipramine hydrochloride 75 mg/1 | CapsuleOral | 16714-851 | 16714-0851-0116714-0851-0216714-0851-03 | — |
| Clomipramine Hydrochloride | Clomipramine hydrochloride 25 mg/1 | CapsuleOral | 16714-849 | 16714-0849-0116714-0849-0216714-0849-03 | — |
| Clomipramine Hydrochloride | Clomipramine hydrochloride 50 mg/1 | CapsuleOral | 16714-850 | 16714-0850-0116714-0850-0216714-0850-03 | — |
| ziprasidone | Ziprasidone hydrochloride 60 mg/1 | CapsuleOral | 16714-837 | 16714-0837-01 | — |
| ziprasidone | Ziprasidone hydrochloride 20 mg/1 | CapsuleOral | 16714-835 | 16714-0835-01 | — |
| ziprasidone | Ziprasidone hydrochloride 40 mg/1 | CapsuleOral | 16714-836 | 16714-0836-01 | — |
| ziprasidone | Ziprasidone hydrochloride 80 mg/1 | CapsuleOral | 16714-838 | 16714-0838-01 | — |
| budesonide | Budesonide 3 mg/1 | Capsule, Coated pelletsOral | 16714-829 | 16714-0829-01 | — |
| Sumatriptansumatriptan succinate | Sumatriptan succinate 50 mg/1 | TabletOral | 16714-797 | 16714-0797-01 | — |
| Sumatriptansumatriptan succinate | Sumatriptan succinate 25 mg/1 | TabletOral | 16714-796 | 16714-0796-01 | — |
| Sumatriptansumatriptan succinate | Sumatriptan succinate 100 mg/1 | TabletOral | 16714-798 | 16714-0798-01 | — |
| Sevelamer Carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 16714-814 | 16714-0814-01 | — |
| atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | 16714-755 | 16714-0755-01 | — |
| atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | 16714-756 | 16714-0756-01 | — |
NorthStar Rx LLC: common questions
- What is NorthStar Rx LLC's NDC labeler code?
- 16714, 72603. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for NorthStar Rx LLC?
- Med-Code's HCPCS directory matches J2506 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.